Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Mar 17, 2026
Date Accepted: Aug 6, 2026

The final, peer-reviewed published version of this preprint can be found here:

Effectiveness of a Virtual Reality Immersion Process as a Nonpharmacological Intervention for Behavioral and Psychological Symptoms of Dementia and Immediate Well-Being in People Living in Nursing Homes: Randomized Controlled Trial

Giroux M, Delphin-Combe F, Rion M, Temedda MN, Dauphinot V, Tripoz-Dit-Masson S, Grange C, Garnier-Crussard A, Dautricourt S

Effectiveness of a Virtual Reality Immersion Process as a Nonpharmacological Intervention for Behavioral and Psychological Symptoms of Dementia and Immediate Well-Being in People Living in Nursing Homes: Randomized Controlled Trial

JMIR Form Res 2026;10:e95542

DOI: 10.2196/95542

PMID: 42837535

Effectiveness of a Virtual Reality Immersion Process as a non-pharmacological intervention on Behavioral and Psychological Symptoms of Dementia and immediate Well Being in people living in Nursing Home: a Randomized Controlled Trial

  • Marion Giroux; 
  • Floriane Delphin-Combe; 
  • Marianne Rion; 
  • Mohamed Nour Temedda; 
  • Virginie Dauphinot; 
  • Stéphanie Tripoz-Dit-Masson; 
  • Clémence Grange; 
  • Antoine Garnier-Crussard; 
  • Sophie Dautricourt

ABSTRACT

Background:

Neuropsychiatric symptoms of dementia (NPS) are common among nursing homes residents, notably those with Alzheimer’s disease, impacting both themselves, and healthcare professionals. Non-pharmacological interventions, including virtual reality, have shown promise, but evidence from multicentre ecological studies remains limited.

Objective:

This study aimed to evaluate the effectiveness of a virtual reality–based immersion intervention (Lumeen©) as a non-pharmacological approach for managing NPS among nursing home residents.

Methods:

56 nursing home residents with NPS took part in this multicentre randomized controlled trial, receiving either virtual reality-based sessions or non-digital cognitive stimulation. Both interventions consisted of two 45-minute group sessions per week for six weeks. NPS severity (NPI, IA-S) was assessed pre- and post-intervention while immediate well-being (EVIBE) and social interaction (SOBRI) were assessed at each session.

Results:

No significant differences were found between groups in NPS reduction or well-being. However, immediate well-being improved in both groups, and social interactions were more frequent in the control group. Only two mild adverse events were reported.

Conclusions:

Virtual reality interventions may enhance immediate well-being with minimal risks but were not superior to cognitive stimulation for NPS reduction. Clinical Trial: The study presented in this article was registered on clinical trial with the name “Virtual Reality Intervention for the Reduction of Behavioral and Psychological Symptoms of Dementia (LUMEENCOMPAD)” ClinicalTrials.gov NCT04769024; https://clinicaltrials.gov/study/NCT04769024


 Citation

Please cite as:

Giroux M, Delphin-Combe F, Rion M, Temedda MN, Dauphinot V, Tripoz-Dit-Masson S, Grange C, Garnier-Crussard A, Dautricourt S

Effectiveness of a Virtual Reality Immersion Process as a Nonpharmacological Intervention for Behavioral and Psychological Symptoms of Dementia and Immediate Well-Being in People Living in Nursing Homes: Randomized Controlled Trial

JMIR Form Res 2026;10:e95542

DOI: 10.2196/95542

PMID: 42837535

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.